The psoriasis market alone is growing from $7.49 Billion per year in 2014 to an estimated $9.02 Billion per year in 2019 and Prurisol will be used also for treatment of psoriatic arthritis, rheumatoid arthritis, multiple myeloma and various other diseases and conditions due to the FACT that Prurisol is a potent inhibitor of IL-20.